Upregulation of LTB4R/LTB4R2 in a subset of TNBC samples suggests that the expression levels of these receptors may be employed in the future as a marker of tumor sensitivity to leukotriene receptor inhibitors. Here, LTB4R2 is linked to neoplasm.